Spyre Therapeutics (SYRE) Q3 2021 Earnings

4NovExpected
Q4 2020
Q1 2021
Q2 2021
Q3 2021
-8.75
-5.89
-3.03
-0.16

Details

Expected EPS
-0.2792
Actual EPS
-7.75
Surprise EPS
-7.47
Surprise Percent
+2,675.79%

Description

Spyre Therapeutics (SYRE) has reported earnings of -7.75 per share for Q3 2021.

0 Comments

Share your thoughts